Photo

613-801-0450

...

Ottawa

English

Claire Palmer, Ph.D.

Senior Patent Agent

Claire Palmer drafts and prosecutes patents in a broad range of technologies including biotechnology, biochemistry, pharmaceuticals, microbiology, biology, molecular biology, bioremediation, biological wastewater treatment and other "green" technologies. Claire also has expertise in the Patented Medicines (Notice of Compliance) Regulations, particularly on issues relating to patent claim eligibility for listing patents.

Claire’s experience in the fields of scientific research revolves around projects relating to bacterial DNA repair, chromatin remodeling, transcriptional regulation and myogenesis. The latter project specifically included analyzing the changes to histone modifications that occur during muscle differentiation, and the role of ATP dependent chromatin remodeling motors in myogenesis.

Her expertise extends to a variety of scientific techniques including a wide range of molecular biology, gene arrays, transcriptional assays and cell culture techniques. Her practice also extends to assisting in patent litigation matters.

Claire is a Registered Canadian Patent Agent and also has limited recognition to represent Canadians in patent matters before the USPTO.

Education

  • Hon. B.Sc., Biology, McMaster University

  • M.Sc., Microbiology, McMaster University

  • Ph.D., Molecular Biology, McMaster University

Professional Involvement

  • Intellectual Property Institute of Canada (IPIC) - Biotechnology Patents Committee

  • Patent Information Users Group (PIUG)

cb photo 70 563d0138742d9

DR. Stuart Bristowe

Patent Agent


Stuart’s practice focuses on the drafting and prosecution of patent applications in various areas of technology.MBM read_more_btn

MBM logo

About MBM

 The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

Clarifications to the Data Protection Guidance Document

Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...Read More